Edition:
United States

ARMO Biosciences Inc (ARMO.OQ)

ARMO.OQ on NASDAQ Stock Exchange Global Select Market

54.34USD
3:59pm EST
Change (% chg)

$0.69 (+1.29%)
Prev Close
$53.65
Open
$56.18
Day's High
$57.00
Day's Low
$54.08
Volume
54,930
Avg. Vol
--
52-wk High
$57.00
52-wk Low
$27.00

Chart for

About

ARMO Biosciences, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company focuses on developing immunotherapies for the treatment of cancer, cardiovascular disease, fibrosis and inflammation. The Company's platform molecule AM0010 is a pegylated form of recombinant human IL-10, which has immune... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $1,524.35
Shares Outstanding(Mil.): 28.41
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 180.40 17.28
EPS (TTM): -- -- --
ROI: -- -0.52 35.61
ROE: -- -3.30 17.17

BRIEF-ARMO Biosciences Sees IPO Of Up To 6.7 Mln Shares Of Common Stock, Estimated IPO Price Between $14 And $16/Shr

* ARMO BIOSCIENCES INC SEES IPO OF UP TO 6.7 MILLION SHARES OF COMMON STOCK AND ESTIMATED IPO PRICE BETWEEN $14.00 AND $16.00 PER SHARE - SEC FILING

Jan 16 2018

Earnings vs. Estimates

No consensus analysis data available.